METHYL 2-(3,4-DIHYDROXYPHENYL)ACETATE, 95.0%, 100g

(3-Fluoro-2-methoxyphenyl)boronic acid, 95.0%, 5g

2-(3-Bromopropoxy)tetrahydro-2H-pyran, 94.0%, 10g

Iron(III) 2,4-pentanedionate 250 g

3-Methyl-4-(2,2,2-trifluoroethoxy)aniline, 96%, 1g

2-(3,4-Dimethoxyphenyl)-5,7,8-trimethoxy-4H-chromen-4-one, 95.0%, 100mg

Zinc molybdate, min. 99%, pure, 100 g, plastic packaging.

4-(4-Chloro-phenyl)-2,4-dioxo-butyric acid methyl ester, 98.0%, 5g

1-(5-ETHYLPYRIMIDIN-2-YL)PIPERIDIN-4-YL METHANESULFONATE, 90.0%, 2g

Ethyl 1-(aminomethyl)cyclopropanecarboxylate hydrochloride, 95.0%, 100mg

2-Methyl-2,5-diazabicyclo[2.2.1]heptanedihydrochloride, 97%, 1g

3-(allyloxy)benzaldehyde, 95.0%, 1g

Butanedioic acid, compd. with 2-chloro-11-(4-methyl-1-piperazinyl)dibenz[b,f][1,4]oxazepine (1:1), 99%, 500mg